4119 (4119) News
Follow 4119 (4119) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
SCI Pharmtech reports Sep revenue of NT$163.4M
SCI Pharmtech Inc. reported September revenue of NT$163,394,000 versus NT$122,806,000 a year earlier, with Jan-Sep revenue at NT$1,151,808,000 versus NT$988,248,000.
EQUITY | Oct 08, 2026, 08:48 AM UTC
M
SCI Pharmtech revenue rises to NT$149.0M in 2026 vs NT$51.8M
SCI Pharmtech Inc. reports 2026 revenue of NT$148,954,000 versus NT$51,806,000 in 2025, and Jan–Aug revenue of NT$988,413,000 versus NT$865,442,000 in 2025, per Taiwan Stock Exchange.
EQUITY | Sep 08, 2026, 08:48 AM UTC